Skip to main content

Drug Policy and Law


Oct 13, 2016
Péter Sárosi
In February 2016, Macedonia legalised medicinal cannabis but the law is far from ideal. Drugreporter’s Macedonian partner, Healthy Options Project Skopje – HOPS – carried out an analysis of the law. Read their key remarks and recommendations presented by Vlatko Dekov.

Sep 22, 2016
Balázs Szigeti
A psychedelic renaissance is happening right now; but before classic hallucinogenic drugs can be accepted into mainstream medicine, their safety must be demonstrated. To move towards this goal, Norwegian scientists published a study claiming that psychedelics are not linked to long-term mental health problems; these findings, however, were quickly challenged. Dose of Science takes a look at the debate.

Sep 13, 2016
Igor Kuzmenko
Watch three short videos produced by Drug User News at Drugreporter, about the state of drug policy and harm reduction in Lithuania, Latvia, and Estonia.

Sep 6, 2016
Péter Sárosi
This movie is featuring the Global Ibogaine Conference that was held in Mexico in March, filmed by a member of Drugreporter’s new global video network and an alumni of our video advocacy training, Brun Balanced and his peers, Karina Muscarina and Gabriel Amezcua.

Sep 5, 2016
Péter Sárosi
Marco Perduca is a leading cannabis reform advocate in Italy and he was one of the first civil society representative who spoke up against the drug conventions at the UN Commission on Narcotic Drugs. We interviewed him about the prospects of cannabis law reform in Italy.

Sep 1, 2016
Péter Sárosi
An interview with Ricardo Fuertes, a young psychologist, about his experiences at working in the harm reduction field in Barcelona and Lisbon.

Aug 12, 2016
Balázs Szigeti
Only a fraction of drug users will ever translate from drug use to drug dependence, yet substance abuse is a great burden, both on the individual and society. Unfortunately, our thinking about addiction is much more shaped by political ideologies than by scientific facts. Addiction is often portrayed as a molecular disease which the individual cannot control by his actions, while conservative narratives often depict it as merely the consequence of an individual’s poor decisions. Neither of these simplistic views covers the whole picture; addiction is a complex phenomenon which has biolo…